Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases.

ABSTRACT: Cardiovascular diseases are the leading cause of death worldwide. Aging and/or metabolic stress directly impact the cardiovascular system. Over the last few years, the contributions of altered nicotinamide adenine dinucleotide (NAD+) metabolism to aging and other pathological conditions closely related to cardiovascular diseases have been intensively investigated. NAD+ bioavailability decreases with age and cardiometabolic conditions in several mammalian tissues. Compelling data suggest that declining tissue NAD+ is commonly related to mitochondrial dysfunction and might be considered as a therapeutic target. Thus, NAD+ replenishment by either genetic or natural dietary NAD+-increasing strategies has been recently demonstrated to be effective for improving the pathophysiology of cardiac an

SUBMITTER: Rotllan N 

PROVIDER: S-EPMC8750485 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature